Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Nobuhide Shinizu to Lead Insmed Japan from January
December 16, 2021
- Takeda Sets Up New Manufacturing Line for Alofisel at Osaka Plant
December 16, 2021
- Kyowa Kirin Files Lumicef for Systemic Sclerosis in Japan
December 16, 2021
- Sumitomo Dainippon Calls Off PIII Cancer Vaccine Study due to Low Probability of Success
December 16, 2021
- Generic Makers Scrambling to Respond to MHLW Request to Lift Shipment Restrictions, Wholesalers Fret Further Confusion
December 15, 2021
- Amenalief Filed for Recurrent Herpes Simplex in Japan: Maruho
December 15, 2021
- Enhertu Filed for Second-Line Breast Cancer Use in Japan: Daiichi Sankyo
December 15, 2021
- Sales Reps’ Online Detailing Jumped 58.7% YOY in October: Intage
December 15, 2021
- Chugai to Tackle Challenging Disease Arenas with Mid-Sized Molecules: R&D Confab
December 14, 2021
- Research Foundation Set Up at Kyoto University after Opdivo Settlement
December 14, 2021
- Sanofi Eyes 2022 Japan NDA for Rare Blood Disease Drug on Positive Data
December 14, 2021
- Redasemtide Yields Positive PII Data in Stroke: Shionogi/StemRIM
December 14, 2021
- Tenapanor Hits Mark in Japan Hyperphosphatemia Study: Kyowa Kirin
December 14, 2021
- Daiichi Sankyo’s Valemetostat Logs 48% Response in Japan ATL Study
December 14, 2021
- Takeda Spinout ARTham Now a Kaken Subsidiary
December 14, 2021
- Lilly’s RET Inhibitor, Pfizer’s Oral JAK Drug Make Japan Debut
December 14, 2021
- Chugai Files Actemra for COVID-19 Pneumonia in Japan
December 14, 2021
- J-TEC’s Ocural, Cell Sheet for Eye Disease, Launched in Japan
December 13, 2021
- Mitsubishi Tanabe Eyes US Submission of Oral Edaravone by March-End
December 13, 2021
- Teva Takeda to Roll Out 2nd Blopress AG in January
December 13, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…